Overview

Seer provides a platform for proteomics by combining its Proteograph system with proprietary nanoparticles and software to enable deep, unbiased, and rapid analysis of the proteome. It captures proteins from complex biological samples using specially designed nanoparticles and then analyzes them with software to identify and quantify proteins, giving researchers a more complete view of protein expression. The platform is used across drug discovery, diagnostics, and basic research, with a business model that includes selling the Proteograph system as well as recurring revenue from consumables and software. Seer's approach stands apart from competitors by delivering broader, more comprehensive proteome coverage through its nanoparticle-based capture combined with data analysis, enabling quicker, more thorough proteomic insights. The company aims to become a leading tool for researchers to gain biological insights and support development in life sciences, genomics, and multi-omics.